Thienopyrimidines are widely represented in the literature, mainly due to their structural relationship with purine base such as adenine and guanine. This current review presents three isomers-thieno[2,3-]pyrimidines, thieno[3,2-]pyrimidines and thieno[3,4-]pyrimidines-and their anti-infective properties. Broad-spectrum thienopyrimidines with biological properties such as antibacterial, antifungal, antiparasitic and antiviral inspired us to analyze and compile their structure-activity relationship (SAR) and classify their synthetic pathways. This review explains the main access route to synthesize thienopyrimidines from thiophene derivatives or from pyrimidine analogs. In addition, SAR study and promising anti-infective activity of these scaffolds are summarized in figures and explanatory diagrams. Ligand-receptor interactions were modeled when the biological target was identified and the crystal structure was solved.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780093PMC
http://dx.doi.org/10.3390/ph15010035DOI Listing

Publication Analysis

Top Keywords

thienopyrimidine promising
4
promising scaffold
4
scaffold access
4
access anti-infective
4
anti-infective agents
4
agents thienopyrimidines
4
thienopyrimidines represented
4
represented literature
4
literature structural
4
structural relationship
4

Similar Publications

Discovery of a novel, selective CK2 inhibitor class with an unusual basic scaffold.

Eur J Med Chem

January 2025

Pharmaceutical and Medicinal Chemistry, Saarland University, Campus C2.3, 66123, Saarbrücken, Germany. Electronic address:

Article Synopsis
  • CK2 is an important enzyme involved in cell growth and survival, making it a potential target for cancer treatments, but many existing inhibitors are not selective enough.
  • Researchers discovered a new compound, a dihydropyrido-thieno[2,3-d]pyrimidine derivative, which showed strong inhibitory activity against CK2α and was notable for its unique chemical structure.
  • The most effective compound, 10b, had an IC value of 36.7 nM and demonstrated good selectivity and cellular activity against certain cancer cell lines, outperforming existing inhibitors in terms of inducing cell death.
View Article and Find Full Text PDF

Phosphatidylinositol 3-kinases (PI3Ks) are widely expressed in tissues and cells throughout the body and are involved in a variety of physiological processes including cell growth and metabolism. The phosphoinositide-3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of the rapamycin (mTOR) signaling pathway (PI3K/AKT/mTOR, PAM) is a promising target for the treatment of many cancer types because it is significantly linked to tumorigenesis and development. Aberrant activation of this pathway is observed in the majority of tumors, particularly in breast cancer.

View Article and Find Full Text PDF

Novel thieno[2,3-d]pyrimidine analogues were designed, synthesized and evaluated for anti-proliferative activity against HepG-2, PC-3 and MCF-7 cancer cell lines. In addition, WI-38 normal cell line was used to explore the safety of all the tested compounds. Compounds 2 (IC = 4.

View Article and Find Full Text PDF

This work describes the design and synthesis of three series of hybrids of thienopyrimidines and sulfonamides. Dihydrofolate reductase enzyme was selected as a target for the in-silico screening of the synthesized thienopyrimidine-sulfonamide hybrid as an antibacterial, while squalene epoxidase was selected as an antifungal target protein. All screened compounds showed promising binding affinity ranges, with perfect fitting not exceeding 1.

View Article and Find Full Text PDF

Eighteen novel compounds harboring the privileged thienopyrimidine scaffold (5a-q, and 6a),were designed based on molecular hybridization strategy. These compounds were synthesized and tested for their inhibitory activity against four different carbonic anhydrase isoforms: CA I, II, IX, and XII. Microwave and conventional techniques were applied for their synthesis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!